Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design.
about
The cellular and molecular basis for malaria parasite invasion of the human red blood cellMerozoite surface proteins in red blood cell invasion, immunity and vaccines against malariaRecent insights into apicomplexan parasite egress provide new views to a killInhibitory potential of prodomain of Plasmodium falciparum protease serine repeat antigen 5 for asexual blood stages of parasiteProtease inhibitors from marine actinobacteria as a potential source for antimalarial compoundPlasmodium falciparum SERA5 plays a non-enzymatic role in the malarial asexual blood-stage lifecycleIn silico approach to ascertain the calcium dependent role of Plasmodium falciparum SERA5.Genetic and structural characterization of PvSERA4: potential implication as therapeutic target for Plasmodium vivax malaria.Inhibition of malaria parasite development by a cyclic peptide that targets the vital parasite protein SERA5.Proteomic profiling of Plasmodium sporozoite maturation identifies new proteins essential for parasite development and infectivityClues to evolution of the SERA multigene family in 18 Plasmodium speciesThe Plasmodium falciparum pseudoprotease SERA5 regulates the kinetics and efficiency of malaria parasite egress from host erythrocytes.The Plasmodium serine-type SERA proteases display distinct expression patterns and non-essential in vivo roles during life cycle progression of the malaria parasite.Protease-associated cellular networks in malaria parasite Plasmodium falciparum.Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria.The role of serine-type serine repeat antigen in Plasmodium yoelii blood stage developmentGlobal identification of multiple substrates for Plasmodium falciparum SUB1, an essential malarial processing protease.Plasmodium subtilisin-like protease 1 (SUB1): insights into the active-site structure, specificity and function of a pan-malaria drug target.Development and Application of a Simple Plaque Assay for the Human Malaria Parasite Plasmodium falciparum.Proteolytic activation of the essential parasitophorous vacuole cysteine protease SERA6 accompanies malaria parasite egress from its host erythrocyte.Recent advances in recombinant protein-based malaria vaccines.Molecular and biochemical characterization of a cathepsin B-like protease family unique to Trypanosoma congolenseEvaluation of the genetic polymorphism of Plasmodium falciparum P126 protein (SERA or SERP) and its influence on naturally acquired specific antibody responses in malaria-infected individuals living in the Brazilian Amazon.Robust inducible Cre recombinase activity in the human malaria parasite Plasmodium falciparum enables efficient gene deletion within a single asexual erythrocytic growth cycleMalarial proteases and host cell egress: an 'emerging' cascade.Expression and processing of Plasmodium berghei SERA3 during liver stages.Improved prediction of malaria degradomes by supervised learning with SVM and profile kernel.A key role for Plasmodium subtilisin-like SUB1 protease in egress of malaria parasites from host hepatocytes.LISP1 is important for the egress of Plasmodium berghei parasites from liver cells.TLR9 and endogenous adjuvants of the whole blood-stage malaria vaccine.Threonine peptidases as drug targets against malaria.Proteases as regulators of pathogenesis: examples from the Apicomplexa.Plasmodium food vacuole plasmepsins are activated by falcipains.CA/C1 peptidases of the malaria parasites Plasmodium falciparum and P. berghei and their mammalian hosts--a bioinformatical analysis.Calcium-dependent phosphorylation of Plasmodium falciparum serine repeat antigen-5 triggers merozoite egress.A tutorial of diverse genome analysis tools found in the CoGe web-platform using Plasmodium spp. as a model.Identification and validation of a novel panel of Plasmodium knowlesi biomarkers of serological exposure.
P2860
Q21032502-BBDB711E-9A5A-429C-9762-22FEF00E2DE2Q26772878-AE23EE34-7E71-48CC-9A10-3DE3BEE43C4FQ27023611-8B73EFCF-CA7F-46FE-B887-7CC9AEF7E953Q28479056-6C21A6AC-C290-487A-9A75-9153E6FB89CAQ28540732-BEF78A64-B5D3-4D06-BCD7-404C47C8A733Q30046956-A3B886CE-5B36-46C9-B8B6-08F50736C91EQ30383100-4772BB04-95CC-43ED-9BD7-45D7E1B9B3AAQ30429329-1017A497-5350-4C8C-95AA-BAE8AB22A409Q33347981-E95A1C04-344B-4E0F-8323-90FCC874FF9CQ33381649-92B038B1-023B-4027-9AD0-B710ACBA1306Q33851402-117D69B6-ABB6-4DDC-A7A5-468389589461Q33880801-B401DE95-C79E-40C7-AA34-D1BA1948B908Q33885507-D0C8C111-3D3F-412A-BAB5-C50E5063B8FBQ34173524-055C8EDE-CC1D-4B32-BBF5-7295E7F6B35FQ34303373-321B7D2F-FC93-4E13-B4D9-52BEB3C53311Q34698064-EAA487F9-5808-4E1D-A70C-6666C0010907Q34739743-BA7D515C-68AE-408D-B7CC-48C7037DB99CQ36045121-9ADA5D73-37A8-4E2A-A776-7482D6DA4AB2Q36058850-4CB7C82C-7F7F-408E-9AE7-40DD74111FA5Q36368252-8BF4544B-16F6-4689-9DB1-1C4AE3CB1D0FQ36394182-49284503-70EF-4C5F-91B1-ACFBA5A8A978Q36538973-F7D57CFF-31AF-4D19-B7A2-576CA17C3D87Q36835626-C23F24A0-7179-4504-BAC4-CC1F7450DEDBQ37001788-DF59C367-6B13-409F-BD92-E9927335215CQ37029523-F8E10555-8AE9-48E1-9F9B-F87EA63D1F0CQ37035500-3A7F8710-6A3E-4514-858F-D8E135592D5CQ37290269-EFF4903C-4A70-4952-B54B-456C95AAC420Q37311442-1A8B1791-2A43-4D84-8214-8C2DA2D55BEDQ37414542-D767773A-D8BE-4920-A3DD-FC258A2653C9Q37771945-EAD3EE37-07C2-4734-BDCD-705A8EB10C1AQ37833642-D575D27C-DC56-4602-815A-5B8088FF87B8Q37891227-C9973738-D59D-44E6-9196-84F6C29B3587Q39647939-73BA5D82-0CEF-419F-932A-E51DBAC152A6Q47910895-BC919F8E-CB02-4D12-A711-2E7D89226931Q54113173-C0A581BB-3D31-4170-8354-6FB47C2C5018Q54941026-C90D6C41-A668-43A6-83A3-C6491414DE1FQ55405299-896BB15B-8632-43B6-B5EA-8336B2DAF22E
P2860
Evidence for a common role for the serine-type Plasmodium falciparum serine repeat antigen proteases: implications for vaccine and drug design.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Evidence for a common role for ...... s for vaccine and drug design.
@ast
Evidence for a common role for ...... s for vaccine and drug design.
@en
type
label
Evidence for a common role for ...... s for vaccine and drug design.
@ast
Evidence for a common role for ...... s for vaccine and drug design.
@en
prefLabel
Evidence for a common role for ...... s for vaccine and drug design.
@ast
Evidence for a common role for ...... s for vaccine and drug design.
@en
P2093
P2860
P921
P356
P1476
Evidence for a common role for ...... s for vaccine and drug design.
@en
P2093
Anthony N Hodder
Joanne E McCoubrie
Robert T Good
Susanne K Miller
Tania F de Koning-Ward
Tobias Sargeant
P2860
P304
P356
10.1128/IAI.00405-07
P407
P577
2007-09-24T00:00:00Z